Literature DB >> 27000228

The difference of apparent diffusion coefficient in the middle cerebellar peduncle among parkinsonian syndromes: Evidence from a meta-analysis.

Wataru Sako1, Nagahisa Murakami2, Yuishin Izumi2, Ryuji Kaji2.   

Abstract

The measurement of middle cerebellar peduncle (MCP) width allows for differential diagnosis between Parkinson's disease (PD) and multiple system atrophy with predominant parkinsonian features (MSA-P). However, it remains controversial whether apparent diffusion coefficient (ADC) value in the MCP of MSA-P is elevated or not. In the present study, we aimed to assess the usefulness of ADC value in the MCP for differential diagnosis between PD and MSA-P. An on-line literature search yielded 5 eligible studies. We expressed between-group difference of ADC value as the standardized mean difference (SMD). The proportion of variation due to heterogeneity was computed and expressed as I(2). ADC in the MCP of MSA-P was significantly increased compared with PD with heterogeneous studies (P=0.0007, I(2)=81%). A meta-regression analysis of MSA-P was conducted for "UPDRS III", and revealed a significant correlation between UPDRS III and SMD (P=0.01). Our meta-regression analysis has clarified the contribution of severity of MSA-P to heterogeneity of the included studies for ADC in the MCP. This finding raised the possibility that ADC in the MCP depended on severity of MSA-P, and less severe patients with MSA-P should be mainly enrolled in future study to assess the ability for differential diagnostic tool.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apparent diffusion coefficient; Meta-analysis; Middle cerebellar peduncle; Multiple system atrophy; Parkinson's disease; Progressive nuclear palsy

Mesh:

Year:  2016        PMID: 27000228     DOI: 10.1016/j.jns.2016.02.034

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

2.  The effect of istradefylline for Parkinson's disease: A meta-analysis.

Authors:  Wataru Sako; Nagahisa Murakami; Keisuke Motohama; Yuishin Izumi; Ryuji Kaji
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

3.  Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Authors:  Trina Mitchell; Bradley J Wilkes; Derek B Archer; Winston T Chu; Stephen A Coombes; Song Lai; Nikolaus R McFarland; Michael S Okun; Mieniecia L Black; Ellen Herschel; Tanya Simuni; Cynthia Comella; Mitra Afshari; Tao Xie; Hong Li; Todd B Parrish; Ajay S Kurani; Daniel M Corcos; David E Vaillancourt
Journal:  Neuroimage Clin       Date:  2022-04-26       Impact factor: 4.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.